These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 29402662)

  • 41. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children.
    Griffiths B; Ducharme FM
    Cochrane Database Syst Rev; 2013 Aug; (8):CD000060. PubMed ID: 23966133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ten-year prescription trends of asthma medications in the management of childhood wheeze.
    Soh JY; Ng B; Tan Z; Xu S; Hing WC; Wu TS; Chan YH; Lee BW
    Allergy Asthma Proc; 2014; 35(1):e1-8. PubMed ID: 24433589
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacist consultations in general practice clinics: the Pharmacists in Practice Study (PIPS).
    Tan EC; Stewart K; Elliott RA; George J
    Res Social Adm Pharm; 2014; 10(4):623-32. PubMed ID: 24095088
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A pharmacist-run anabolic osteoporosis clinic: An abaloparatide descriptive report.
    McGreevy JL; Kane MP; Busch RS; Bakst G; ElDeiry S
    J Am Pharm Assoc (2003); 2019; 59(4):593-597. PubMed ID: 31101442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
    Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
    BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of asthma medication adherence rates and strategies to improve adherence in the underserved population at a Federally Qualified Health Center.
    Bidwal M; Lor K; Yu J; Ip E
    Res Social Adm Pharm; 2017; 13(4):759-766. PubMed ID: 27595427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of a pharmacist-led outpatient direct oral anticoagulant service.
    Ashjian E; Kurtz B; Renner E; Yeshe R; Barnes GD
    Am J Health Syst Pharm; 2017 Apr; 74(7):483-489. PubMed ID: 28336758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prescription of oral short-acting beta 2-agonist for asthma in non-resource poor settings: A national study in Malaysia.
    Chin MC; Sivasampu S; Khoo EM
    PLoS One; 2017; 12(6):e0180443. PubMed ID: 28662193
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacist-managed patient assessment and medication refill clinic.
    D'Achille KM; Swanson LN; Hill WT
    Am J Hosp Pharm; 1978 Jan; 35(1):66-70. PubMed ID: 414621
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of inappropriate use of short acting beta agonists in asthma.
    FitzGerald JM; Tavakoli H; Lynd LD; Al Efraij K; Sadatsafavi M
    Respir Med; 2017 Oct; 131():135-140. PubMed ID: 28947020
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Obtaining optimal control in mild asthma: theory and practice.
    Watson L; Kerstjens HA; Rabe KF; Kiri V; Visick GT; Postma DS
    Fam Pract; 2005 Jun; 22(3):305-10. PubMed ID: 15805133
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessing care team perspectives on integration of a community pharmacist into an ambulatory care practice.
    Riggins SR; Abode AM; Holland CR; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2019; 59(4S):S122-S128.e1. PubMed ID: 31231003
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The clinical pharmacist interventions to improve the immunosuppressive therapy management in a pediatric population: education, adherence, pharmacovigilance].
    Adamo A; Provenzani A; Polidori P
    Recenti Prog Med; 2016 Jan; 107(1):39-49. PubMed ID: 26901368
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beneficial effect of a pharmacist refill evaluation clinic.
    Jones RJ; Goldman MP; Rockwood RP; Imhoff TE
    Hosp Pharm; 1987 Feb; 22(2):166-8. PubMed ID: 10280300
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overuse of short-acting beta-agonist bronchodilators in COPD during periods of clinical stability.
    Fan VS; Gylys-Colwell I; Locke E; Sumino K; Nguyen HQ; Thomas RM; Magzamen S
    Respir Med; 2016 Jul; 116():100-6. PubMed ID: 27296828
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors influencing community pharmacists' likelihood to ask medication monitoring questions: A factorial survey.
    Witry MJ; Doucette WR
    Res Social Adm Pharm; 2015; 11(5):639-50. PubMed ID: 25573019
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development and implementation of a postdischarge home-based medication management service.
    Pherson EC; Shermock KM; Efird LE; Gilmore VT; Nesbit T; LeBlanc Y; Brotman DJ; Deutschendorf A; Swarthout MD
    Am J Health Syst Pharm; 2014 Sep; 71(18):1576-83. PubMed ID: 25174018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of health disparities on staff workload in pharmacist-managed anticoagulation clinics.
    Meade M; Borchert J; Griffin B; Kliethermes MA; Komperda K
    Am J Health Syst Pharm; 2011 Aug; 68(15):1430-5. PubMed ID: 21785033
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcomes assessment of a pharmacist-directed seamless care program in an ambulatory oncology clinic.
    Edwards SJ; Abbott R; Edwards J; LeBlanc M; Dranitsaris G; Donnan J; Laing K; Whelan MA; MacKinnon NJ
    J Pharm Pract; 2014 Feb; 27(1):46-52. PubMed ID: 24065784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.